Our findings provide evidence supporting the potential value of COHb examination in clinic as a convenient and easy tool for the diagnosis and prognostic evaluation of CRC, and suggesting that inhibition of HO-1 may be a option to enhance the chemotherapeutic effects of conventional anticancer drugs toward CRC. The gene discussed is HMOX1; the disease is colorectal carcinoma.